{"bill":{"bill_id":1688974,"change_hash":"a949a2b9eeb1460aebd78aa70eee8eec","session_id":2002,"session":{"session_id":2002,"state_id":42,"year_start":2023,"year_end":2024,"prefile":0,"sine_die":0,"prior":0,"special":0,"session_tag":"Regular Session","session_title":"2023-2024 Regular Session","session_name":"113th General Assembly"},"url":"https:\/\/legiscan.com\/TN\/bill\/HB1501\/2023","state_link":"https:\/\/wapp.capitol.tn.gov\/apps\/Billinfo\/default.aspx?BillNumber=HB1501&ga=113","completed":0,"status":1,"status_date":"2023-01-31","progress":[{"date":"2023-01-31","event":1},{"date":"2023-02-02","event":9}],"state":"TN","state_id":42,"bill_number":"HB1501","bill_type":"B","bill_type_id":"1","body":"H","body_id":89,"current_body":"H","current_body_id":89,"title":"AN ACT to amend Tennessee Code Annotated, Title 53 and Title 63, relative to opioids.","description":"As introduced, requires a prescribing healthcare practitioner to discuss certain risks associated with a prescribed Schedule II controlled substance prior to an initial prescription and following the third prescription of the drug during a course of treatment; requires the practitioner to document the discussion of such risks in the patient\u2019s medical record. - Amends TCA Title 53 and Title 63.","pending_committee_id":0,"committee":[],"referrals":[{"date":"2023-02-02","committee_id":3430,"chamber":"H","chamber_id":89,"name":"Health"}],"history":[{"date":"2023-01-31","action":"Filed for introduction","chamber":"H","chamber_id":89,"importance":1},{"date":"2023-02-01","action":"Intro., P1C.","chamber":"H","chamber_id":89,"importance":0},{"date":"2023-02-02","action":"P2C, ref. to Health Committee","chamber":"H","chamber_id":89,"importance":1},{"date":"2023-02-07","action":"Assigned to s\/c Health Subcommittee","chamber":"H","chamber_id":89,"importance":0}],"sponsors":[{"people_id":20343,"person_hash":"9rcqu1vu","party_id":"1","state_id":42,"party":"D","role_id":1,"role":"Rep","name":"Yusuf Hakeem","first_name":"Yusuf","middle_name":"A.","last_name":"Hakeem","suffix":"","nickname":"","district":"HD-028","ftm_eid":9464809,"votesmart_id":160425,"opensecrets_id":"","knowwho_pid":662597,"ballotpedia":"Yusuf_Hakeem","bioguide_id":"","sponsor_type_id":1,"sponsor_order":1,"committee_sponsor":0,"committee_id":0,"state_federal":0}],"sasts":[{"type_id":5,"type":"Crossfiled","sast_bill_number":"SB1020","sast_bill_id":1687580}],"subjects":[{"subject_id":321387,"subject_name":"Opioids"}],"texts":[{"doc_id":2673562,"date":"2023-01-31","type":"Draft","type_id":9,"mime":"application\/pdf","mime_id":2,"url":"https:\/\/legiscan.com\/TN\/text\/HB1501\/id\/2673562","state_link":"https:\/\/www.capitol.tn.gov\/Bills\/113\/Bill\/HB1501.pdf","text_size":11629,"text_hash":"4bc139011e54b18ca082f6e8039ffccb"}],"votes":[],"amendments":[],"supplements":[{"supplement_id":307179,"date":"2023-02-16","type":"Fiscal Note","type_id":1,"title":"Fiscal Note","description":"SB1020","mime":"application\/pdf","mime_id":2,"url":"https:\/\/legiscan.com\/TN\/supplement\/HB1501\/id\/307179","state_link":"https:\/\/www.capitol.tn.gov\/Bills\/113\/Fiscal\/SB1020.pdf","supplement_size":102292,"supplement_hash":"59cb94c79603d9b8c2b5b70f86ec68c8"}],"calendar":[]}}